KORU Medical Systems, Inc. (KRMD)
KRMD moved a median of +0.09% 30 minutes after news, and -0.54% by the close. How KRMD actually reacts to news — the realized, point-in-time move the market made, measured across 267 labeled events over the last three years with zero look-ahead.
KRMD’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 33% | 244 |
| 30-min | +0.09% | 51% | 263 |
| 60-min | 0.00% | 48% | 267 |
| to close | -0.54% | 41% | 259 |
| Middle 50% of KRMD reactions | -0.94% to +1.25% |
|---|---|
| Median reaction (30-min) | +0.09% |
| Measured reactions | 267 |
Half of all KORU Medical Systems, Inc. news events land between -0.94% and +1.25% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when KRMD moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to KRMD's baseline. Nothing else.
Recent KRMD events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K KORU Medical Systems, For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.18% | |
| Form 10-Q KORU Medical Systems, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.20% | -5.32% | |
| Form 8-K KORU Medical Systems, For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | +1.20% | -5.32% | |
| KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance | Press release | Business Wire | +1.20% | -5.32% | |
| KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference | Press release | Business Wire | +0.72% | -0.96% | |
| Kaskela Law LLC Announces Investigation of KORU Medical Systems, Inc. (KRMD) and Encourages Long-Term KRMD Shareholders to Contact the Firm | Press release | Business Wire | +0.00% | -2.87% | |
| KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026 | Press release | Business Wire | +5.06% | +2.17% | |
| Form 8-K KORU Medical Systems, For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | +0.77% | +4.51% | |
| Form 8-K KORU Medical Systems, For: May 19 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.91% | |
| KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress | Press release | Business Wire | -0.26% | +2.86% | |
| Form 10-Q KORU Medical Systems, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +2.34% | -1.11% | |
| Form 8-K KORU Medical Systems, For: May 06 | SEC filing · Form 8-K | SEC EDGAR | +2.34% | -1.11% | |
| KORU Medical Systems Announces First Quarter 2026 Results | Press release | Business Wire | +2.34% | -1.11% | |
| KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026 | Press release | Business Wire | -1.40% | -2.56% | |
| Form DEF 14A KORU Medical Systems, For: Dec 31 | SEC filing · Form DEF | SEC EDGAR | -0.69% | -3.66% | |
| Form 8-K KORU Medical Systems, For: Mar 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.16% | |
| Form 8-K KORU Medical Systems, For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | +1.64% | +0.23% | |
| KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility | Press release | Business Wire | +0.46% | -0.70% | |
| Form 10-K KORU Medical Systems, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.46% | -0.70% | |
| Form 8-K KORU Medical Systems, For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | +0.46% | -0.70% | |
| KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance | Press release | Business Wire | +0.46% | -0.70% | |
| KORU Medical Systems Announces CEO Transition | Press release | Business Wire | +0.46% | -0.70% | |
| KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 | Press release | Business Wire | +4.28% | -2.85% | |
| Form 8-K KORU Medical Systems, For: Feb 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.56% | |
| KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System | Press release | Business Wire | +0.00% | -1.28% | |
| Form 8-K KORU Medical Systems, For: Jan 12 | SEC filing · Form 8-K | SEC EDGAR | +5.18% | +14.72% | |
| KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow | Press release | Business Wire | +1.07% | +5.56% | |
| Form S-8 KORU Medical Systems, | SEC filing · Form S-8 | SEC EDGAR | +0.00% | -0.54% | |
| KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | Business Wire | +0.00% | -0.54% | |
| KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic | Press release | Business Wire | +0.70% | +1.40% | |
| KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer | Press release | Business Wire | -2.50% | -4.84% | |
| Form 8-K KORU Medical Systems, For: Nov 19 | SEC filing · Form 8-K | SEC EDGAR | +0.19% | +11.75% | |
| KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025 | Press release | Business Wire | +1.04% | -0.22% | |
| KORU Medical Systems to Participate in Upcoming Investor Conferences | Press release | Business Wire | +0.00% | — | |
| Form 10-Q KORU Medical Systems, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | — | |
| Form 8-K KORU Medical Systems, For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | — | |
| KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance | Press release | Business Wire | +0.00% | — | |
| KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems | Press release | Business Wire | -2.84% | +4.13% | |
| KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025 | Press release | Business Wire | — | -0.47% | |
| ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy | Press release | Business Wire | -3.75% | +1.00% | |
| Cirtec Medical Announces Appointment of New Chief Executive Officer | Press release | GlobeNewswire | +0.00% | -0.94% | |
| Form S-8 KORU Medical Systems, | SEC filing · Form S-8 | SEC EDGAR | -0.72% | +3.12% | |
| Form 10-Q KORU Medical Systems, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +2.57% | +13.49% | |
| Form 8-K KORU Medical Systems, For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | +2.57% | +13.49% | |
| KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance | Press release | Business Wire | +2.57% | +13.49% | |
| KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | Business Wire | -0.57% | -3.43% | |
| KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference | Press release | Business Wire | +0.00% | -0.86% | |
| KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025 | Press release | Business Wire | -1.60% | +5.43% | |
| KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer | Press release | Business Wire | +0.82% | +3.54% | |
| KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes | Press release | Business Wire | +1.26% | +0.95% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the KRMD section they belong to.
Where else KRMD is measured.
KRMD earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is KORU Medical Systems, Inc.'s median reaction calculated?
Every labeled KRMD news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 267 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of KRMD's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does KRMD's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.